PMBL: Clinical Trials

1 trial for PMBL, newest first

ClinicalTrials Daily  ·  Areas  ·  Conditions  ·  Drugs  ·  Sponsors  ·  

1 recruiting. 1 Phase 1.

By phase and status

PhaseTrialsStatus
Phase 11Recruiting 1

Follow PMBL: new trials by email Literature Review of PMBL trials Research Report on PMBL

Trials newest first · largest first

Tick up to 5 trials to compare them side by side (eligibility, arms, endpoints, adverse events) in a Literature Matrix.

TrialPhaseStatusSponsorEnrollmentStartUpdated
Clinical Study of C402-CD19-CAR Treatment in Subjects With Relapsed or Refractory B-cell Lymphoma
C402-CD19-CAR - Diffuse Large B-cell-lymphoma, DLBCL, Nos Genetic Subtypes
Phase 1RecruitingShanghai Exuma Biotechnology Ltd.182025-03-252026-09-11

Narrower conditions

Dendritic Cell Sarcoma, Interdigitating (1)  ·  Lymphoma, B-Cell (1)  ·  Pyloric Stenosis, Hypertrophic (1)

Broader conditions

Digestive System Diseases (1)  ·  Gastric Outlet Obstruction (1)  ·  Gastrointestinal Diseases (1)  ·  Hemic and Lymphatic Diseases (1)  ·  Histiocytic Disorders, Malignant (1)  ·  Histiocytosis (1)  ·  Immune System Diseases (1)  ·  Immunoproliferative Disorders (1)  ·  Lymphatic Diseases (1)  ·  Lymphoma (1)  ·  Lymphoma, Non-Hodgkin (1)  ·  Lymphoproliferative Disorders (1)  ·  Neoplasms (1)  ·  Neoplasms by Histologic Type (1)  ·  Pyloric Stenosis (1)

Sponsors

Shanghai Exuma Biotechnology Ltd. (1)

Countries

China (1)

Top investigators

Liang Huang, MD (1)

Results publications

PMID 28153605, PMID 28478586, PMID 31744509, PMID 35398840